Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review

被引：18

作者：

Prieto-Pena, Diana ^{[4
]}

Bernabeu, Pilar ^{[5
]}

Vela, Paloma ^{[5
]}

Narvaez, Javier ^{[6
]}

Fernandez-Lopez, Jesus C. ^{[7
]}

Freire-Gonzalez, Mercedes ^{[7
]}

Gonzalez-Alvarez, Beatriz ^{[8
]}

Solans-Laque, Roser ^{[9
]}

Callejas Rubio, Jose L. ^{[10
]}

Ortego, Norberto ^{[10
]}

Fernandez-Diaz, Carlos ^{[11
]}

Rubio, Esteban ^{[12
]}

Garcia-Morillo, Salvador ^{[12
]}

Minguez, Mauricio ^{[13
]}

Fernandez-Carballido, Cristina ^{[13
]}

de Miguel, Eugenio ^{[14
]}

Melchor, Sheila ^{[15
]}

Salgado, Eva ^{[16
]}

Bravo, Beatriz ^{[17
]}

Romero-Yuste, Susana ^{[18
]}

Salvatierra, Juan ^{[10
]}

Hidalgo, Cristina ^{[19
]}

Manrique, Sara ^{[20
]}

Romero-Gomez, Carlos ^{[20
]}

Moya, Patricia ^{[21
]}

Alvarez-Rivas, Noelia ^{[22
]}

Mendizabal, Javier ^{[23
]}

Ortiz-Sanjuan, Francisco ^{[24
]}

Perez de Pedro, Ivan ^{[25
]}

Alonso-Valdivielso, Jose L. ^{[26
]}

Perez-Sanchez, Laura ^{[27
]}

Roldan, Rosa ^{[27
]}

Fernandez-Llanio, Nagore ^{[28
]}

Gomez de la Torre, Ricardo ^{[29
]}

Suarez, Silvia ^{[29
]}

Montesa Cabrera, Maria Jesus ^{[8
]}

Delgado Sanchez, Monica ^{[8
]}

Loricera, Javier ^{[4
]}

Atienza-Mateo, Belen ^{[4
]}

Castaneda, Santos ^{[11
,30
]}

Gonzalez-Gay, Miguel A. ^{[1
,2
,3
]}

Blanco, Ricardo ^{[4
]}

机构：

[1] Hosp Univ Marques de Valdecilla, Rheumatol Div, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, IDIVAL, Ave Valdecilla S-N, Santander 39008, Spain

[2] Univ Cantabria, Sch Med, Santander, Spain

[3] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa

[4] Hosp Univ Marques de Valdecilla, Dept Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, Santander, Spain

[5] Hosp Gen Alicante, Dept Rheumatol, Alicante, Spain

[6] Hosp Bellvitge Princeps Espanya, Dept Rheumatol, Barcelona, Spain

[7] Complejo Hosp Univ A Coruna, Dept Rheumatol, La Coruna, Spain

[8] Hosp Nuestra Senora Candelaria, Dept Rheumatol, Tenerife, Spain

[9] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain

[10] Hosp San Cecilio, Autoimmune Dis Unit, Granada, Spain

[11] Hosp Univ Princesa, Dept Rheumatol, IIS Princesa, Madrid, Spain

[12] Hosp Virgen Rocio, Autoimmune Dis Unit, Seville, Spain

[13] Hosp San Juan Alicante, Dept Rheumatol, Alicante, Spain

[14] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain

[15] Hosp Univ 12 Octubre, Dept Rheumatol, Madrid, Spain

[16] Complejo Hosp Univ Ourense, Dept Rheumatol, Orense, Spain

[17] Hosp Virgen Nieves, Dept Rheumatol, Granada, Spain

[18] Complejo Hosp Univ Pontevedra, Dept Rheumatol, Pontevedra, Spain

[19] Complejo Univ Salamanca, Dept Rheumatol, Salamanca, Spain

[20] Hosp Reg Malaga, Autoimmune Dis Unit, Malaga, Spain

[21] Hosp Santa Creu & Sant Pau, Dept Rheumatol, Barcelona, Spain

[22] Hosp Univ San Agustin, Dept Rheumatol, Aviles, Spain

[23] Complejo Hosp Navarra, Dept Rheumatol, Pamplona, Spain

[24] Hosp Univ & Politecn La Fe, Dept Rheumatol, Valencia, Spain

[25] Hosp Carlos Haya, Autoimmune Dis Unit, Malaga, Spain

[26] Hosp Univ Burgos, Dept Rheumatol, Burgos, Spain

[27] Hosp Univ Reina Sofia, Dept Rheumatol, Cordoba, Spain

[28] Hosp Arnau Vilanova, Dept Rheumatol, Valencia, Spain

[29] Hosp Univ Cent Asturias, Autoimmune Dis Unit, Oviedo, Spain

[30] Univ Autonoma Madrid IUAMI, UAM ROCHE, EPID Future, Madrid, Spain

来源：

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE | 2021年 / 13卷

关键词：

biological therapy; Caucasian; cDMARDs; Takayasu's arteritis; Tocilizumab; DISEASE-ACTIVITY; EPIDEMIOLOGY; EFFICACY; FEATURES; CRITERIA; OUTCOMES; SAFETY; JAPAN;

D O I：

10.1177/1759720X211020917

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu's arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-sparing effect, improvement in imaging techniques, and adverse events. A comparative study between patients who received TCZ as monotherapy (TCZ(MONO)) and combined with conventional disease modifying anti-rheumatic drugs (cDMARDs) (TCZ(COMBO)) was performed. Results: The study comprised 54 patients (46 women/8 men) with a median [interquartile range (IQR)] age of 42.0 (32.5-50.5) years. TCZ was started after a median (IQR) of 12.0 (3.0-31.5) months since TAK diagnosis. Remission was achieved in 12/54 (22.2%), 19/49 (38.8%), 23/44 (52.3%), and 27/36 (75%) patients at 1, 3, 6, and 12 months, respectively. The prednisone dose was reduced from 30.0 mg/day (12.5-50.0) to 5.0 (0.0-5.6) mg/day at 12 months. An improvement in imaging findings was reported in 28 (73.7%) patients after a median (IQR) of 9.0 (6.0-14.0) months. Twenty-three (42.6%) patients were on TCZ(MONO) and 31 (57.4%) on TCZ(COMBO): MTX (n = 28), cyclosporine A (n = 2), azathioprine (n = 1). Patients on TCZ(COMBO) were younger [38.0 (27.0-46.0) versus 45.0 (38.0-57.0)] years; difference (diff) [95% confidence interval (CI) = -7.0 (-17.9, -0.56] with a trend to longer TAK duration [21.0 (6.0-38.0) versus 6.0 (1.0-23.0)] months; diff 95% CI = 15 (-8.9, 35.5), and higher c-reactive protein [2.4 (0.7-5.6) versus 1.3 (0.3-3.3)] mg/dl; diff 95% CI = 1.1 (-0.26, 2.99). Despite these differences, similar outcomes were observed in both groups (log rank p = 0.862). Relevant adverse events were reported in six (11.1%) patients, but only three developed severe events that required TCZ withdrawal. Conclusion: TCZ in monotherapy, or combined with cDMARDs, is effective and safe in patients with refractory TAK of Caucasian origin.

引用

页数：12

共 50 条

[31] TOCILIZUMAB IN EXTRACRANIAL LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: COMPARATIVE MULTICENTER STUDY
Lasa-Teja, C.
Loricera, J.
Prieto-Pena, D.
Lopez-Gutierrez, F.
Bernabeu, P.
Gonzalez, M. Freire
Gonzalez-Alvarez, B.
Solans-Laque, R.
Minguez, M.
Ferraz-Amaro, I.
Castaneda, S.
Blanco, R.
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
[32] Takayasu's arteritis in a young Caucasian female: case report and review
Schurgers, M.
Dujardin, K.
Crevits, I.
Mortelmans, L.
Blockmans, D.
ACTA CLINICA BELGICA, 2007, 62 (03) : 177 - 183
[33] SAFETY AND EFFICACY OF SHORT-TERM TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS
Novikov, P.
Smitienko, I.
Elonakov, A.
Koilubaeva, G.
Moiseev, S.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 302 - 302
[34] Tocilizumab throughout pregnancy in two patients with severe Takayasu's arteritis
Cruz-Machado, A. R.
Silva, Andrade L.
Barreira, S. C.
Veiga, A.
Ponte, C.
Pinto, L.
Macieira, C.
Capela, S.
ACTA REUMATOLOGICA PORTUGUESA, 2021, 46 (02): : 192 - 194
[35] Efficacy and Tolerance of Infliximab In Refractory Takayasu Arteritis: French Multicenter Study
Mekinian, Arsene
Neel, Antoine
Sibilia, Jean
Cohen, Pascal
Connault, Jerome
Lambert, Marc
Federici, Laure
Berthier, Sabine
Feissinger, Jean Noel
Godeau, Bertrand
Marie, Isabelle
Guillevin, Loic
Hamidou, Mohamed
Fain, Olivier
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S586 - S586
[36] EFFECTIVENESS AND SAFETY OF INTRAVENOUS VERSUS SUBCUTANEOUS TOCILIZUMAB IN TAKAYASU ARTERITIS: MULTICENTER RETROSPECTIVE STUDY
Mekinian, A.
Saadoun, D.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 639 - 639
[37] TOCILIZUMAB IN REFRACTORY AORTITIS: STUDY ON 16 PATIENTS AND LITERATURE REVIEW
Loricera, J.
Blanco, R.
Castaneda, S.
Humbria, A.
Ortego-Centeno, N.
Narvaez, J.
Mata, C.
Melchor, S.
Aurrecoechea, E.
Calvo-Alen, J.
Lluch, P.
Moll, C.
Minguez, M.
Herrero-Beaumont, G.
Bravo, B.
Rubio, E.
Freire, M.
Peiro, E.
Gonzalez-Vela, M. C.
Rueda-Gotor, J.
Pina, T.
Calvo-Rio, V.
Ortiz-Sanjuan, F.
Gonzalez-Gay, M. A.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 694 - 694
[38] Tocilizumab in refractory aortitis: a study on 16 patients and literature review
Loricera, J.
Blanco, R.
Castaneda, S.
Humbria, A.
Ortego-Centeno, N.
Narvaez, J.
Mata, C.
Melchor, S.
Aurrecoechea, E.
Calvo-Alen, J.
Lluch, P.
Moll, C.
Minguez, M.
Herrero-Beaumont, G.
Bravo, B.
Rubio, E.
Freire, M.
Peiro, E.
Gonzalez-Vela, C.
Rueda-Gotor, J.
Pina, T.
Palmou-Fontana, N.
Calvo-Rio, V.
Ortiz-Sanjuan, F.
Gonzalez-Gay, M. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S79 - S89
[39] Takayasu's arteritis in pregnancy: review of literature and discussion
Hauenstein, Evelyn
Frank, Helga
Bauer, Jan S.
Schneider, K. T. M.
Fischer, Thorsten
JOURNAL OF PERINATAL MEDICINE, 2010, 38 (01) : 55 - 62
[40] Refractory Takayasu's Arteritis with Severe Coronary Involvement-Case Report and Literature Review
Cobilinschi, Claudia Oana
Gradinaru, Elena
Saulescu, Ioana
Carstea, Nicolae
Caraiola, Simona
Balanescu, Andra Rodica
Opris-Belinski, Daniela
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)

← 1 2 3 4 5 →